Last update 01 Nov 2024

Ferring Pharmaceuticals Korea Co., Ltd.

Subsidiary Company|
2004|
South Korea
|
www.ferring.co.kr

Overview

Tags

Endocrinology and Metabolic Disease
Neoplasms
Skin and Musculoskeletal Diseases
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Neoplasms1
Top 5 Drug TypeCount
Synthetic peptide1
Top 5 TargetCount
GnRHR(Gonadotropin-releasing hormone receptor)1

Related

2
Drugs associated with Ferring Pharmaceuticals Korea Co., Ltd.
Degarelix Acetate
Target
GnRHR
Mechanism
GnRHR antagonists
Active Org.
Ferring Pharmaceuticals A/SFerring Pharmaceuticals A/S [+5]
Originator Org.
Ferring BV
Active Indication
Castration-sensitive prostate cancer [+5]
Inactive Indication
Advanced Prostate Carcinoma [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date24 Dec 2008
Triptorelin Pamoate
Target
GnRHR
Mechanism
GnRHR agonists
Active Org.
Ipsen (Tianjin) Pharmaceutical Trade Co., Ltd.Ipsen (Tianjin) Pharmaceutical Trade Co., Ltd. [+8]
Originator Org.
Actavis A/S
Active Indication
Puberty, Precocious [+4]
Inactive Indication
Endometriosis [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
KR
First Approval Date04 Nov 1996
4
Clinical Trials associated with Ferring Pharmaceuticals Korea Co., Ltd.
KCT0004067 / Active, not recruitingNot Applicable
Treatment patterns and clinical outcomes of Recombinant Follicle Stimulating Hormone in South Korean patients who received Controlled Ovarian Hyper-stimulation: Results from a retrospective observational chart review study
KCT0001223 / RecruitingNot Applicable
The effect of minirin® on sleeping and voiding pattern to whom circadian rhythmic changed work-shift nurses
NCT01215513 / CompletedPhase 3
An Open-Label, Multi-Centre, Extension Trial, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients Requiring Androgen Ablation Therapy
100 Clinical Results associated with Ferring Pharmaceuticals Korea Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Ferring Pharmaceuticals Korea Co., Ltd.
Login to view more data
100 Deals associated with Ferring Pharmaceuticals Korea Co., Ltd.
Login to view more data
100 Translational Medicine associated with Ferring Pharmaceuticals Korea Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Triptorelin Pamoate
 ( GnRHR )		Prostatic Cancer
More
Approved
Degarelix Acetate
 ( GnRHR )		Prostatic Cancer
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free